Investigational Site Number : 6300003

Guayama 00784

0 studies enrolling now · 2 studies all time

What they study most

Respiratory Syncytial Virus Immunization, Respiratory Syncytial Virus Infection

Studies at this site

• Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older — Completed
• Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA) — Completed